Freshpaint, a healthcare marketing performance platform, has partnered with MNTN to enable privacy-compliant Connected TV advertising for healthcare marketers. The integration allows organisations to measure CTV campaign performance whilst maintaining HIPAA compliance and protecting patient data. Freshpaint captures conversions using privacy-first behavioural data, ensuring no Protected Health Information leaves the healthcare organisation's environment. Only de-identified conversion signals are sent to MNTN for campaign optimisation and reporting. The partnership addresses a longstanding challenge for healthcare marketers, who have typically found CTV too complex to measure and navigate whilst maintaining privacy compliance. Healthcare organisations can now attribute campaigns to specific actions like appointment bookings and purchases, proving return on investment without exposing sensitive patient information.

Magnite has partnered with MNTN to give advertisers access to premium streaming content, including live sports and news, with new ad formats and AI-driven targeting. Despite the partnership, Magnite's shares have declined 13% over 30 days and 25% over 90 days. The company reported revenue of $702.6 million and net income of $58 million. Shares trade at a price-to-earnings ratio of 35.4x versus the US media industry average of 14.3x, suggesting overvaluation by traditional metrics. However, a discounted cash flow model estimates intrinsic value at $48.91 per share, compared to the current price of $14.29, indicating potential undervaluation. The company's one-year total shareholder return stands at negative 13%, whilst the five-year return shows a 61% decline.

MNTN Inc.'s (NYSE:MNTN) lock-up period ends on November 18th, allowing major shareholders and insiders to sell shares. MNTN issued 11.7 million shares in its IPO on May 22nd, raising $187.2 million at $16 per share. Analysts have mixed ratings, with a consensus "Moderate Buy" and a price target of $27.15. MNTN shares opened at $13.93, with a 12-month range of $13.30 to $32.49. Institutional investors own 72.9% of the stock.